Authors
Latest:
Overview of PARP Inhibitors in the Treatment of Ovarian CancerThere are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Latest:
Case Report: Rivastigmine Overexposure Toxicities with Weight LossWith gastrointestinal-based adverse effectss for rivastigmine and other cholinesterase inhibitors, a weight of <50 and <55 kg respectively leads to an increased risk for toxicities.
Latest:
The Role of the Ambulatory Care Pharmacist in Promoting Vaccine ConfidenceA pharmacist’s role in the ambulatory care setting has traditionally included a review of medications for potential drug-drug interactions and adverse events, medication reconciliation, and the provision of counseling services.
Latest:
Overcharging Hospital Pharmacies: Unnecessary Hidden CostsIn hospital pharmacies, roughly 2% of pharmacy spend can be overcharge.
Latest:
I Think When I Am Older, I Might Be a Pharmacist! My Experience Writing a Children's Book About PharmacyChildren's books about the field of pharmacy are surprisingly scarce.
Latest:
Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes DiagnosticWhen diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.
Latest:
Updated C. Difficile Infection Guidelines Incorporate New TrialsInfectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.
Latest:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapeThis review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Latest:
Naloxone Training Requirements Vary Among StatesNew access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.
Latest:
Pharma Moves Toward Value-Based ContractingPart 1 of this 4-part series provides a general overview of the trends that are moving payers and pharmaceutical companies in this direction.
Latest:
COVID-19 Booster Shots and the FutureKey opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Latest:
Health System-Based Specialty Pharmacy Offers Unique Advantages in HIV CareSpecialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.
Latest:
The Role of a Clinical Pharmacist in Melanoma Care and EducationBecause of the likelihood that patients with melanoma will develop adverse effects on therapy, it is crucial for pharmacists to proactively educate patients and provide them with tools to help mitigate and manage these issues.
Latest:
Overview of Nurtec ODT for Prevention of Episodic MigraineNurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Latest:
The Role of Pharmacists in HIV Care Continues to ExpandPharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
Latest:
Lower Discontinuation Rates on Cycled Oral Antineoplastics Can Lead to Lower Medical Costs, Fewer HospitalizationsThese agents are likely to become the mainstay of cancer treatment in the very near future.
Latest:
CDC and FDA Recommendations for SARS-CoV-2 Booster ShotsExperts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
Latest:
Evaluation of Factors Driving Rheumatoid Arthritis Moderate to High Disease Activity on Routine Assessment of Patient Index Data 3 ScoreUtilization of the RAPID3 tool can be a beneficial way for pharmacists to complete disease activity assessments without physically seeing the patient in a clinic setting.
Latest:
Managing Blood Glucose Levels for Expectant Mothers With DiabetesCGM enhances diabetes management in pregnancy, improving outcomes.
Latest:
Data Analytics Help Specialty Pharmacies Personalize Health CareAdvanced analytics will continue to make health care more accessible and empower pharmacists with the ability to personalize treatments.
Latest:
How I Overcame My Battle With Autoimmune Disease to Become a PharmacistAlthough it is critical that we listen to every patient we treat, it's also important to listen to the needs of our bodies first, as this will allow us to better care for others.
Latest:
Study: Probiotic with Vitamin D Supplements Could Aid Individuals with SchizophreniaVitamin D deficiency (VDD) is an important factor in the pathogens of schizophrenia.
Latest:
What is Needed to Turn the COVID-19 Pandemic into an EndemicFor COVID-19 to turn into an endemic, there are a few criteria that must be met.
Latest:
Clinical Overview: Oral Diabetes Medications in ChildrenDespite the surge in new diabetes cases, the treatment options in in children remain limited.
Latest:
Medically Integrated Pharmacies, Oral Oncolytic Agents Grow in Importance During COVID-19As practices have gained experience in the post-COVID-19 environment, health care professionals have found innovative ways to work around many of the obstacles the pandemic presents.
Latest:
Technology Can Help Ease Provider Burnout, Access to Health CareThe need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.
Latest:
With DSCSA Compliance Delay, Certain Requirements Still Require Action NowLaunching development of SOPs and communication with wholesalers is key.
Latest:
California Modifies End of Life Option ActAmendments reflecting more contemporary options could raise ethical questions for health care workers.
Latest:
Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 DiabetesPatients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.
